1





                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549
                                              

                                  FORM 10-Q/A

     X      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
            OF THE SECURITIES EXCHANGE ACT OF 1934

            For the quarter ended September 30, 1994

                                       OR

            TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
            OF THE SECURITIES EXCHANGE ACT OF 1934

            For the transition period from ________ to ________

                         Commission file number 1-10235

                                IDEX Corporation                           
             (Exact name of registrant as specified in its charter)

        Delaware                           36-3555336            
State or other jurisdiction of           (I.R.S. Employer
incorporation or organization           Identification No.)


630 Dundee Road, Suite 400
Northbrook, Illinois                               60062              
(Address of principal executive offices)      (Zip Code)

Registrant's telephone number, including area code  (708) 498-7070


________________________________________________________________
Former name, former address and former fiscal year,
if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by section 13 or 15(d) of the securities exchange act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.  yes x   no
   
Number of shares of common stock of IDEX Corporation ("IDEX" or the "Company")
outstanding as of November 4, 1994:  12,716,386 shares.

Documents Incorporated by Reference:  None.
   2





                          Part II.  Other Information



Item 6.   Exhibits and Reports on Form 8-K

          (a)  Exhibits

               The exhibits listed in the accompanying "Exhibit Index"
               are filed as part of this report.

          (b)  Reports on Form 8-K

               There have been no reports on Form 8-K filed during the
               quarter for which this report is filed.





                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized in the capacity and on the date
indicated. 





                                      IDEX CORPORATION





January 4, 1994                    /s/Wayne P. Sayatovic        
                                      Wayne P. Sayatovic
                                      Senior Vice President-
                                      Finance, Chief Financial
                                      Officer and Secretary
                                      (Duly Authorized and Principal
                                      Financial Officer)

                                      1
   3





                                 EXHIBIT INDEX

Exhibit
Number                Description                                  Page
- - -------               -----------                                  ----

*27               Financial Data Schedule





- - ---------------               
*Filed herewith

                                      2
   4
Appendix A to Item 601(c) of Regulation S-K
Commercial and Industrial Companies

Article 5 of Regulation S-X

Financial Data Schedule
September 30, 1994
                                                                          
Item Number Item Description Amount - - ----------- ---------------- ------ 5-02(1) cash and cash items $ 3,715 5-02(2) marketable securities 5-02(3)(a)(1) notes and accounts receivable-trade 61,888 5-02(4) allowance for doubtful accounts 1,920 5-02(6) inventory 80,117 5-02(9) total current assets 151,113 5-02(13) property, plant and equipment 185,300 5-02(14) accumulated depreciation 118,866 5-02(18) total assets 370,546 5-02(21) total current liabilities 59,260 5-02(22) bonds, mortgages and similar debt 75,000 5-02(28) preferred stock-mandatory redemption 5-02(29) preferred stock-no mandatory redemption 5-02(30) common stock 127 5-02(31) other stockholders' equity 109,044 5-02(32) total liabilities and stockholders' equity 370,546 5-03(b)1(a) net sales of tangible products 286,408 5-03(b)1 total revenues 286,408 5-03(b)2(a) cost of tangible goods sold 176,226 5-03(b)(2) total costs and expenses applicable to sales and revenues 237,027 5-03(b)(3) other costs and expenses 1,773 5-03(b)5 provision for doubtful accounts and notes 234 5-03(b)(8) interest and amortization of debt discount 9,728 5-03(b)(10) income before taxes and other items 37,880 5-03(b)(11) income tax expense 13,505 5-03(b)(14) income/loss continuing operations 24,375 5-03(b)(15) discontinued operations 5-03(b)(17) extraordinary items 5-03(b)(18) cumulative effect-changes in accounting principles 5-03(b)(19) net income 24,375 5-03(b)(20) earnings per share-primary 1.87 5-03(b)(20) earnings per share-fully diluted